Marea takes drug for acromegaly to Phase 2news2026-01-13T13:00:12+00:00January 13th, 2026|Endpoints News|
Novartis licenses radiopharma asset from Chinese biotech for $50M upfrontnews2026-01-13T12:07:22+00:00January 13th, 2026|Endpoints News|
#JPM26: Day 2 at the JP Morgan Healthcare Conferencenews2026-01-13T12:00:15+00:00January 13th, 2026|Endpoints News|
Sentynl gets the first US approval for rare copper absorption diseasenews2026-01-13T10:49:44+00:00January 13th, 2026|Endpoints News|
Treg biotech Sonoma sheds staff after getting new CEOnews2026-01-13T09:13:48+00:00January 13th, 2026|Endpoints News|
Congress’ biotech panel pitches FDA policy upgrades to help performancenews2026-01-13T05:01:10+00:00January 13th, 2026|Endpoints News|
Pretzel buys Rome and its ‘dark genome’ worknews2026-01-12T21:37:31+00:00January 12th, 2026|Endpoints News|
Nvidia-partnered startup reveals AI-generated enzymes for precise gene insertionnews2026-01-12T21:18:10+00:00January 12th, 2026|Endpoints News|
#JPM26: Novo Nordisk CEO says pharma can learn from the GLP-1 compounding boomnews2026-01-12T20:55:09+00:00January 12th, 2026|Endpoints News|
At FDA’s request, Pfizer helps ease shortage of potential autism drugnews2026-01-12T19:49:26+00:00January 12th, 2026|Endpoints News|
